Genomics Software Application Development

02/ Curation

Outsourcing Product Development

We have a strong track record in product development for complex Genomic Applications, e.g., GeneSpring and MassProfiler Pro, for Agilent and StrandNGS. We extend our software development services to US-based large diagnostics, instrument, and reagent companies. We are an Illumina ICA implementation partner and have similar relationships with Agilent as well as a large pharma and diagnostics company, to name only 3 of our notable clientele.

02/ Curation

Algorithm Verification and Validation (CDx/IVD)

We have deep experience building and validating algorithms and software accompanying NGS assays, including generating hand-crafted test cases and clinical-grade documentation.

02/ Curation

Bioinformatics Product Development for Internal Use

We leverage our expertise in secondary and tertiary NGS software to build custom tools that empower our India clinical diagnostics business. Together, StrandNGS and StrandOmics enable end-to-end secondary analysis and variant reporting for somatic, inherited cancer risk, and rare disease exome panels, supporting approximately 10,000 tests per annum.

StrandNGS is our integrated platform for NGS secondary analysis, management, and visualization.
StrandOmics is our HIPAA-compliant platform for variant classification and interpretation, thus powering NGS tertiary analysis.

02/ Solution

Custom Software Solutions

QXDx BCR-ABL Reporter

Strand has developed the QXDx BCR-ABL Reporter tool for customers of Bio-Rad Laboratories’ QXDx™ BCR-ABL %IS (CE-IVD) Kit. The kit enables the detection and monitoring of BCR-ABL fusions in patients with Chronic Myeloid Leukemia.

ICA Partner

Strand is an official Illumina Connected Analytics (ICA) Implementation Partner, and we’re equipped with software, bioinformatics, and systems integration capabilities to aid ICA customers.

AWS Select Tier Partner

Strand is an AWS Select Tier Partner, recognized for certified expertise and proven customer impact in cloud-native genomics and multi-omics solutions. Using AWS services for high-performance computing, secure data management, and AI/ML, we help organizations process and analyze large-scale biological data securely, efficiently, and at scale for research and innovation across genomics and life sciences.

03/ Getting curious about our RWD solutions

Frequently Asked Questions

MPP is a chemometrics software package for MS analysis developed by Strand for Agilent. It allows for the convenient import of various types of MS data, such as GC/MS and LC/MS, from large sample sets and complex experiments. MPP integrates advanced statistical tools and visualizations for differential analysis, univariate and multivariate statistics, pattern recognition, variable reduction, and more.

See Read more about Strand-Agilent Collaboration - Mass Profiler Professional for more information.

Strand’s approach involves comprehensive unit testing, performance assessments, and documentation to meet FDA-IVD standards. We also focus on optimization for speed. In a recent engagement, we achieved up to a 300-fold increase in the performance speed of certain secondary analysis pipelines for a key customer.

See A Case Study on Verification and Validation for a Dx Major for more information.

Strand employs extensive unit testing with several hundred hand-crafted test cases for each component, achieving greater than 90% test coverage each time. We have also documented procedures to meet FDA-IVD standards.

See A Case Study on Verification and Validation for a Dx Major for more information.

Yes, Strand has a proven track record of customizing workflow management solutions to meet the specific needs of clients, including implementing NGS analysis pipelines in different computing environments. We recently implemented secondary analysis NGS pipelines in Nextflow and Snakemake for two diagnostics clients.

See A Case Study on Workflow Management Systems for Bioinformatics Companies for more information.

StrandOmics is a cloud-based, HIPAA-compliant platform developed by Strand for variant classification and interpretation. It enables visualization, prioritization, and reporting of somatic variants. This customizable platform has played a pivotal role in generating over 30,000 clinical reports for our diagnostics business and global customers.

See Showcasing Strand’s Expertise: A Closer Look at StrandOmics for more information.

03/ CONNECT

Let's Connect

Name

Phone number

Email address

Write your message here

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.